ESC 365 - Cardiac amyloidosis: when translational approaches and personalised medicine become reality - discussion

HFA Premium Access

Cardiac amyloidosis: when translational approaches and personalised medicine become reality - discussion

Session: Cardiac amyloidosis: when translational approaches and personalised medicine become reality

Topic: Cardiomyopathies

Event: Heart Failure 2024

Congress Presentation

Add to my library

3 more presentations in this session

Pathophysiology and epidemiology

Speaker: Professor T. Damy (Creteil, FR)

Staging and prognostic markers

Speaker: Doctor D. Tomasoni (Brescia, IT)

New therapeutic opportunities: from mechanisms to clinical practice

Speaker: Professor M. Fontana (London, GB)

Access the full session

Cardiac amyloidosis: when translational approaches and personalised medicine become reality

Speakers: Professor T. Damy, Doctor D. Tomasoni, Professor M. Fontana

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources